← SynDRA
KU-55933
SynDRA canonical compound SYN0006737 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ATM |
|---|
| Mechanism of action | ATM kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ATM kinase inhibitor
- ATM inhibitor
- PRKDC INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HDAC6
- PIK3CA
- SYK
- PIK3CB
- MTOR
- ABL1
- PKN2
- PDGFRB
- PDPK1
- PHKG2
- PIK3CG
- PIM1
- PIM2
- PIM3
- PLK1
- PASK
- PLK2
- PLK3
- PRKACA
- PRKCA
- PRKCB
- PRKCD
- PRKCE
- PRKCG
- PRKCH
- PRKCI
- PRKCQ
- PDGFRA
- PAK5
- PAK6
- PRKD1
- MAPKAPK5
- MARK1
- MARK2
- MELK
- MERTK
- MET
- MINK1
- MKNK2
- MST1R
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- KU 55933
- ATM Kinase Inhibitor
- KU55933
- 2-Morpholino-6-(thianthren-1-yl)-4H-pyran-4-one
- 2-Morpholin-4-yl-6-thianthren-1-ylpyran-4-one
- 2-Morpholin-4-yl-6-thianthren-1-yl-pyran-4-one
- UNII-O549494L5D
- CHEMBL222102
- KU-55933 (ATM Kinase Inhibitor)
- O549494L5D
- 2-morpholino-6-thianthren-1-yl-pyran-4-one
- 2-(4-Morpholinyl)-6-(1-thianthrenyl)-4H-pyran-4-one
- 4H-Pyran-4-one, 2-(4-morpholinyl)-6-(1-thianthrenyl)-
- AC1NQSSP
- PubChem22474
- cc-73
- SCHEMBL1984941
- GTPL5928
- 2-Thianthren-1-yl-6-(morpholin-4-yl)-4H-pyran-4-one
- 2-(morpholin-4-yl)-6-(thianthren-1-yl)-4H-pyran-4-one
- RefChem:151494
- DTXCID90130007
- MFCD08276985
- KU-0064
- C21H17NO3S2
- KU55933 (ATM Kinase Inhibitor)
- orb1305169
- SCHEMBL29372172
- CHEBI:91372
- EX-A074
- YQF2795
- XRKYMMUGXMWDAO-UHFFFAOYSA-N
- GLXC-04279
- HMS3229A06
- HMS3244O07
- HMS3244O08
- HMS3244P07
- HMS3265M15
- HMS3265M16
Look up KU-55933 in the interactive SynDRA portal →